awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38030053-69168CFF-78DD-43F0-BC83-A87CBB37820B
Q38030053-69168CFF-78DD-43F0-BC83-A87CBB37820B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38030053-69168CFF-78DD-43F0-BC83-A87CBB37820B
Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?
P2860
Q38030053-69168CFF-78DD-43F0-BC83-A87CBB37820B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38030053-69168CFF-78DD-43F0-BC83-A87CBB37820B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
337810789ab9c59929351bc059c2b49cfbf741f4
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.